Demonstration of quality of care measurement using the Japanese liver cancer registry

Takahiro Higashi, Kiyoshi Hasegawa, Norihiro Kokudo, Masatoshi Makuuchi, Namiki Izumi, Takafumi Ichida, Masatoshi Kudo, Yonson Ku, Michiie Sakamoto, Osamu Nakashima, Osamu Matsui, Yutaka Matsuyama, Tomotaka Sobue

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Aim: Despite advances in medical therapy, studies have reported gaps between current evidence and actual practice in many areas of medicine. Process-of-care quality indicators (QIs) are tools to measure the evidence-practice gap. This study aims to examine the feasibility of applying QIs for liver cancer care to the national registry database operated by the Liver Cancer Study Group of Japan. Methods: Prior research developed a set of process-of-care QIs developed on the basis of the Japanese Clinical Practice Guidelines for hepatocellular carcinoma. Each QI describes target patients and care processes indicated for such patients. Among the 25 developed QIs, six appeared scorable using the information contained in the dataset from the 17th Nationwide Survey of Primary Liver Cancer. Results: In total, 16187 patients were eligible for the six QIs for 34599 times, among which the indicated care was provided 83.9% times. The scores ranged from 64.4% (surgical therapy in patients with HCC 3-5cm in diameter) to 91.1% (indocyanine green checkup before surgical resection). The information was generally available to determine eligibility (78.3%-100%) and pass/fail (91.9%-99.9%) for the QIs. Conclusions: Applying QIs to the liver cancer registry, the quality of hepatocellular carcinoma care can be measured. In future, providing feedback regarding the results to the participating society may improve the quality of liver cancer care nationwide.

Original languageEnglish
Pages (from-to)1208-1215
Number of pages8
JournalHepatology Research
Volume41
Issue number12
DOIs
Publication statusPublished - 2011 Dec

Fingerprint

Quality of Health Care
Liver Neoplasms
Registries
Hepatocellular Carcinoma
Indocyanine Green
Practice Guidelines
Patient Care
Japan
Medicine
Databases
Therapeutics
Research

Keywords

  • Cancer registry
  • Hepatocellular carcinoma
  • Quality indicators
  • Quality of health care

ASJC Scopus subject areas

  • Hepatology
  • Infectious Diseases

Cite this

Higashi, T., Hasegawa, K., Kokudo, N., Makuuchi, M., Izumi, N., Ichida, T., ... Sobue, T. (2011). Demonstration of quality of care measurement using the Japanese liver cancer registry. Hepatology Research, 41(12), 1208-1215. https://doi.org/10.1111/j.1872-034X.2011.00880.x

Demonstration of quality of care measurement using the Japanese liver cancer registry. / Higashi, Takahiro; Hasegawa, Kiyoshi; Kokudo, Norihiro; Makuuchi, Masatoshi; Izumi, Namiki; Ichida, Takafumi; Kudo, Masatoshi; Ku, Yonson; Sakamoto, Michiie; Nakashima, Osamu; Matsui, Osamu; Matsuyama, Yutaka; Sobue, Tomotaka.

In: Hepatology Research, Vol. 41, No. 12, 12.2011, p. 1208-1215.

Research output: Contribution to journalArticle

Higashi, T, Hasegawa, K, Kokudo, N, Makuuchi, M, Izumi, N, Ichida, T, Kudo, M, Ku, Y, Sakamoto, M, Nakashima, O, Matsui, O, Matsuyama, Y & Sobue, T 2011, 'Demonstration of quality of care measurement using the Japanese liver cancer registry', Hepatology Research, vol. 41, no. 12, pp. 1208-1215. https://doi.org/10.1111/j.1872-034X.2011.00880.x
Higashi, Takahiro ; Hasegawa, Kiyoshi ; Kokudo, Norihiro ; Makuuchi, Masatoshi ; Izumi, Namiki ; Ichida, Takafumi ; Kudo, Masatoshi ; Ku, Yonson ; Sakamoto, Michiie ; Nakashima, Osamu ; Matsui, Osamu ; Matsuyama, Yutaka ; Sobue, Tomotaka. / Demonstration of quality of care measurement using the Japanese liver cancer registry. In: Hepatology Research. 2011 ; Vol. 41, No. 12. pp. 1208-1215.
@article{272ae8f6944746d9bf3c55bf2e2ed2fe,
title = "Demonstration of quality of care measurement using the Japanese liver cancer registry",
abstract = "Aim: Despite advances in medical therapy, studies have reported gaps between current evidence and actual practice in many areas of medicine. Process-of-care quality indicators (QIs) are tools to measure the evidence-practice gap. This study aims to examine the feasibility of applying QIs for liver cancer care to the national registry database operated by the Liver Cancer Study Group of Japan. Methods: Prior research developed a set of process-of-care QIs developed on the basis of the Japanese Clinical Practice Guidelines for hepatocellular carcinoma. Each QI describes target patients and care processes indicated for such patients. Among the 25 developed QIs, six appeared scorable using the information contained in the dataset from the 17th Nationwide Survey of Primary Liver Cancer. Results: In total, 16187 patients were eligible for the six QIs for 34599 times, among which the indicated care was provided 83.9{\%} times. The scores ranged from 64.4{\%} (surgical therapy in patients with HCC 3-5cm in diameter) to 91.1{\%} (indocyanine green checkup before surgical resection). The information was generally available to determine eligibility (78.3{\%}-100{\%}) and pass/fail (91.9{\%}-99.9{\%}) for the QIs. Conclusions: Applying QIs to the liver cancer registry, the quality of hepatocellular carcinoma care can be measured. In future, providing feedback regarding the results to the participating society may improve the quality of liver cancer care nationwide.",
keywords = "Cancer registry, Hepatocellular carcinoma, Quality indicators, Quality of health care",
author = "Takahiro Higashi and Kiyoshi Hasegawa and Norihiro Kokudo and Masatoshi Makuuchi and Namiki Izumi and Takafumi Ichida and Masatoshi Kudo and Yonson Ku and Michiie Sakamoto and Osamu Nakashima and Osamu Matsui and Yutaka Matsuyama and Tomotaka Sobue",
year = "2011",
month = "12",
doi = "10.1111/j.1872-034X.2011.00880.x",
language = "English",
volume = "41",
pages = "1208--1215",
journal = "Hepatology Research",
issn = "1386-6346",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "12",

}

TY - JOUR

T1 - Demonstration of quality of care measurement using the Japanese liver cancer registry

AU - Higashi, Takahiro

AU - Hasegawa, Kiyoshi

AU - Kokudo, Norihiro

AU - Makuuchi, Masatoshi

AU - Izumi, Namiki

AU - Ichida, Takafumi

AU - Kudo, Masatoshi

AU - Ku, Yonson

AU - Sakamoto, Michiie

AU - Nakashima, Osamu

AU - Matsui, Osamu

AU - Matsuyama, Yutaka

AU - Sobue, Tomotaka

PY - 2011/12

Y1 - 2011/12

N2 - Aim: Despite advances in medical therapy, studies have reported gaps between current evidence and actual practice in many areas of medicine. Process-of-care quality indicators (QIs) are tools to measure the evidence-practice gap. This study aims to examine the feasibility of applying QIs for liver cancer care to the national registry database operated by the Liver Cancer Study Group of Japan. Methods: Prior research developed a set of process-of-care QIs developed on the basis of the Japanese Clinical Practice Guidelines for hepatocellular carcinoma. Each QI describes target patients and care processes indicated for such patients. Among the 25 developed QIs, six appeared scorable using the information contained in the dataset from the 17th Nationwide Survey of Primary Liver Cancer. Results: In total, 16187 patients were eligible for the six QIs for 34599 times, among which the indicated care was provided 83.9% times. The scores ranged from 64.4% (surgical therapy in patients with HCC 3-5cm in diameter) to 91.1% (indocyanine green checkup before surgical resection). The information was generally available to determine eligibility (78.3%-100%) and pass/fail (91.9%-99.9%) for the QIs. Conclusions: Applying QIs to the liver cancer registry, the quality of hepatocellular carcinoma care can be measured. In future, providing feedback regarding the results to the participating society may improve the quality of liver cancer care nationwide.

AB - Aim: Despite advances in medical therapy, studies have reported gaps between current evidence and actual practice in many areas of medicine. Process-of-care quality indicators (QIs) are tools to measure the evidence-practice gap. This study aims to examine the feasibility of applying QIs for liver cancer care to the national registry database operated by the Liver Cancer Study Group of Japan. Methods: Prior research developed a set of process-of-care QIs developed on the basis of the Japanese Clinical Practice Guidelines for hepatocellular carcinoma. Each QI describes target patients and care processes indicated for such patients. Among the 25 developed QIs, six appeared scorable using the information contained in the dataset from the 17th Nationwide Survey of Primary Liver Cancer. Results: In total, 16187 patients were eligible for the six QIs for 34599 times, among which the indicated care was provided 83.9% times. The scores ranged from 64.4% (surgical therapy in patients with HCC 3-5cm in diameter) to 91.1% (indocyanine green checkup before surgical resection). The information was generally available to determine eligibility (78.3%-100%) and pass/fail (91.9%-99.9%) for the QIs. Conclusions: Applying QIs to the liver cancer registry, the quality of hepatocellular carcinoma care can be measured. In future, providing feedback regarding the results to the participating society may improve the quality of liver cancer care nationwide.

KW - Cancer registry

KW - Hepatocellular carcinoma

KW - Quality indicators

KW - Quality of health care

UR - http://www.scopus.com/inward/record.url?scp=82255185603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82255185603&partnerID=8YFLogxK

U2 - 10.1111/j.1872-034X.2011.00880.x

DO - 10.1111/j.1872-034X.2011.00880.x

M3 - Article

VL - 41

SP - 1208

EP - 1215

JO - Hepatology Research

JF - Hepatology Research

SN - 1386-6346

IS - 12

ER -